請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/88929
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 蔡孟勳 | zh_TW |
dc.contributor.advisor | Mong-Hsun Tsai | en |
dc.contributor.author | 胡兆棨 | zh_TW |
dc.contributor.author | Zhao-Qi Hu | en |
dc.date.accessioned | 2023-08-16T16:24:14Z | - |
dc.date.available | 2023-11-09 | - |
dc.date.copyright | 2023-08-16 | - |
dc.date.issued | 2023 | - |
dc.date.submitted | 2023-08-08 | - |
dc.identifier.citation | [1] L. A. David, C. F. Maurice, R. N. Carmody, et al., “Diet rapidly and reproducibly alters the human gut microbiome,” Nature, vol. 505, no. 7484, pp. 559–563, 2014, doi: https://doi.org/10.1038/nature12820.
[2] A. Panduro, I. Rivera-Iñiguez, M. Sepulveda-Villegas, and S. Roman, “Genes, emotions and gut microbiota: The next frontier for the gastroenterologist,” World J. Gastroenterol., vol. 23, no. 17, p. 3030, 2017, doi: https://doi.org/10.3748/wjg.v23.i17.3030. [3] S. R. Konstantinov, “Diet, microbiome, and colorectal cancer,” Best Pract. & Research Clin. Gastroenterol., vol. 31, no. 6, pp. 675–681, 2017, doi: https://doi.org/10.1016/j.bpg.2017.09.007. [4] A. E. Mohr, R. Jäger, K. C. Carpenter, et al., “The athletic gut microbiota,” J. Int. Soc. Sports Nutr., vol. 17, no. 1, p. 24, 2020, doi: https://doi.org/10.1186/s12970-020-00353-w. [5] B. Ramakrishna, “Probiotic bacteria and their effect on human health and well-being,” Indian J. Med. Research, vol. 140, no. 1, pp. 155–155, 2014. [6] M. X. Maldonado-Gómez, I. Martı́nez, F. Bottacini, et al., “Stable engraftment of Bifidobacterium longum AH1206 in the human gut depends on individualized features of the resident microbiome,” Cell host & microbe, vol. 20, no. 4, pp. 515–526, 2016, doi: https://doi.org/10.1016/j.chom.2016.09.001. [7] I. Allali, R. E. Abotsi, L. A. Tow, et al., “Human microbiota research in africa: A systematic review reveals gaps and priorities for future research,”Microbiome, vol. 9, no. 1, p. 241, 2021, doi: https://doi.org/10.1186/s40168-021-01195-7. [8] S. L. McLellan, J. C. Fisher, and R. J. Newton, “The microbiome of urban waters,” Int. Microbiol., vol. 18, no. 3, p. 141, 2015, doi: https://doi.org/10.2436%2F20.1501.01.244. [9] X. Ding, W. Lan, and J.-D. Gu, “A review on sampling techniques and analytical methods for microbiota of cultural properties and historical architecture,” Appl. Sci., vol. 10, no. 22, p. 8099, 2020, doi: https://doi.org/10.3390/app10228099. [10] Y. S. Bukin, Y. P. Galachyants, I. Morozov, S. Bukin, A. Zakharenko, and T. Zemskaya, “The effect of 16S rRNA region choice on bacterial community metabarcoding results,” Sci. Data, vol. 6, no. 1, pp. 1–14, 2019, doi: https://doi.org/10.1038/sdata.2019.7. [11] B. Yang, Y. Wang, and P.-Y. Qian, “Sensitivity and correlation of hypervariable regions in 16S rRNA genes in phylogenetic analysis,” BMC bioinformatics, vol. 17, no. 1, pp. 1–8, 2016, doi: https://doi.org/10.1186/s12859-016-0992-y. [12] J. S. Johnson, D. J. Spakowicz, B.-Y. Hong, et al., “Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis,” Nat. Commun., vol. 10, no. 1, p. 5029, 2019, doi: https://doi.org/10.1038/s41467-019-13036-1. [13] M.-A. Osman, H.-m. Neoh, N.-S. Ab Mutalib, S.-F. Chin, and R. Jamal, “16S rRNA gene sequencing for deciphering the colorectal cancer gut microbiome: Current protocols and workflows,” Front. Microbiol., vol. 9, p. 767, 2018, doi: https://doi.org/10.3389/fmicb.2018.00767. [14] F. de Melo, F. C. Milanesi, P. D. M. Angst, and R. V. Oppermann, “A systematic review of the microbiota composition in various peri-implant conditions: Data from 16S rRNA gene sequencing,” Arch. Oral Biol., vol. 117, p. 104776, 2020, doi: https://doi.org/10.1016/j.archoralbio.2020.104776. [15] A. E. Lindell, M. Zimmermann-Kogadeeva, and K. R. Patil, “Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota,” Nat. Rev. Microbiol., vol. 20, no. 7, pp. 431–443, 2022, doi: https://doi.org/10.1038/s41579-022-00681-5. [16] J. Li, F. Zhao, Y. Wang, et al., “Gut microbiota dysbiosis contributes to the development of hypertension,” Microbiome, vol. 5, pp. 1–19, 2017, doi: https://doi.org/10.1186/s40168-016-0222-x. [17] D. C. Baumgart and S. R. Carding, “Inflammatory bowel disease: Cause and immunobiology,” The Lancet, vol. 369, no. 9573, pp. 1627–1640, 2007, doi: https://doi.org/10.1016/S0140-6736(07)60750-8. [18] E. Amabebe, F. O. Robert, T. Agbalalah, and E. S. Orubu, “Microbial dysbiosis-induced obesity: Role of gut microbiota in homoeostasis of energy metabolism,” Br. J. Nutr., vol. 123, no. 10, pp. 1127–1137, 2020, doi: https://doi.org/10.1017/S0007114520000380. [19] L. B. Bindels, N. M. Delzenne, P. D. Cani, and J. Walter, “Towards a more comprehensive concept for prebiotics,” Nat. Rev. Gastroenterol Hepatol., vol. 12, no. 5, pp. 303–310, 2015, doi: https://doi.org/10.1038/nrgastro.2015.47. [20] D. Mohanty, S. Misra, S. Mohapatra, and P. S. Sahu, “Prebiotics and synbiotics: Recent concepts in nutrition,” Food bioscience, vol. 26, pp. 152–160, 2018, doi: https://doi.org/10.1016/j.fbio.2018.10.008. [21] G. R. Gibson, R. Hutkins, M. E. Sanders, et al., “Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics,” Nat. Rev. Gastroenterol Hepatol., vol. 14, no. 8, pp. 491–502, 2017, doi: https://doi.org/10.1038/nrgastro.2017.75. [22] H. D. Holscher, “Dietary fiber and prebiotics and the gastrointestinal microbiota,” Gut microbes, vol. 8, no. 2, pp. 172–184, 2017, doi: https://doi.org/10.1080/19490976.2017.1290756. [23] D. Zeevi, T. Korem, N. Zmora, et al., “Personalized nutrition by prediction of glycemic responses,” Cell, vol. 163, no. 5, pp. 1079–1094, 2015, doi: https://doi.org/10.1016/j.cell.2015.11.001. [24] J. Suez, T. Korem, D. Zeevi, et al., “Artificial sweeteners induce glucose intolerance by altering the gut microbiota,” Nature, vol. 514, no. 7521, pp. 181–186, 2014, doi: https://doi.org/10.1038/nature13793. [25] J. Qin, Y. Li, Z. Cai, et al., “A metagenome-wide association study of gut microbiota in type 2 diabetes,” Nature, vol. 490, no. 7418, pp. 55–60, 2012, doi: https://doi.org/10.1038/nature11450. [26] L. A. Frame, E. Costa, and S. A. Jackson, “Current explorations of nutrition and the gut microbiome: A comprehensive evaluation of the review literature,” Nutr. Rev., vol. 78, no. 10, pp. 798–812, 2020, doi: https://doi.org/10.1093/nutrit/nuz106. [27] J. K. Nicholson, E. Holmes, J. Kinross, et al., “Host-gut microbiota metabolic interactions,” Science, vol. 336, no. 6086, pp. 1262–1267, 2012, doi: https://doi.org/10.1126/science.1223813. [28] N. T. Baxter, A. W. Schmidt, A. Venkataraman, K. S. Kim, C. Waldron, and T. M. Schmidt, “Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers,” MBio, vol. 10, no. 1, pp. e02566–18, 2019, doi: https://doi.org/10.1128/mBio.02566-18. [29] S. Deleu, K. Machiels, J. Raes, K. Verbeke, and S. Vermeire, “Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?” EBioMedicine, vol. 66, p. 103293, 2021, doi: https://doi.org/10.1016/j.ebiom.2021.103293. [30] T. Tsukahara, Y. Iwasaki, K. Nakayama, and K. Ushida, “Stimulation of butyrate production in the large intestine of weaning piglets by dietary fructooligosaccharides and its influence on the histological variables of the large intestinal mucosa,” J. Nutr. Sci. Vitaminol. (Tokyo), vol. 49, no. 6, pp. 414–421, 2003, doi: https://doi.org/10.3177/jnsv.49.414. [31] L. Klampfer, J. Huang, T. Sasazuki, S. Shirasawa, and L. Augenlicht, “Inhibition of interferon γ signaling by the short chain fatty acid butyrate,” Mol. Cancer Res., vol. 1, no. 11, pp. 855–862, 2003. [32] A. M. Sheflin, C. L. Melby, F. Carbonero, and T. L. Weir, “Linking dietary patterns with gut microbial composition and function,” Gut microbes, vol. 8, no. 2, pp. 113–129, 2017, doi: https://doi.org/10.1080/19490976.2016.1270809. [33] L. Barrea, G. Annunziata, G. Muscogiuri, et al., “Trimethylamine N-oxide, mediterranean diet, and nutrition in healthy, normal-weight adults: Also a matter of sex?” Nutrition, vol. 62, pp. 7–17, 2019, doi: https://doi.org/10.1016/j.nut.2018.11.015. [34] P. Jantchou, S. Morois, F. Clavel-Chapelon, M.-C. Boutron-Ruault, and F. Carbonnel, “Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study,” Off. journal Am. College Gastroenterol. ACG, vol. 105, no. 10, pp. 2195–2201, 2010, doi: https://doi.org/10.1038/ajg.2010.192. [35] M. Hall and R. G. Beiko, “16S rRNA gene analysis with QIIME2,” Microbiome analysis: methods protocols, pp. 113–129, 2018, doi: https://doi.org/10.1007/978-1-4939-8728-3_8. [36] Y.-M. Hung, T.-P. Lu, M.-H. Tsai, L.-C. Lai, and E. Y. Chuang, “EasyMAP: A user-friendly online platform for analyzing 16S ribosomal DNA sequencing data,” New Biotechnol., vol. 63, pp. 37–44, 2021, doi: https://doi.org/10.1016/j.nbt.2021.03.001. [37] G. Allard, F. J. Ryan, I. B. Jeffery, and M. J. Claesson, “SPINGO: A rapid species-classifier for microbial amplicon sequences,” BMC bioinformatics, vol. 16, no. 1, pp. 1–8, 2015, doi: https://doi.org/10.1186/s12859-015-0747-1. [38] N. Segata, J. Izard, L. Waldron, et al., “Metagenomic biomarker discovery and explanation,” Genome Biol., vol. 12, pp. 1–18, 2011, doi: https://doi.org/10.1186/gb-2011-12-6-r60. [39] G. M. Douglas, V. J. Maffei, J. R. Zaneveld, et al., “PICRUSt2 for prediction of metagenome functions,” Nat. Biotechnol., vol. 38, no. 6, pp. 685–688, 2020, doi: https://doi.org/10.1038/s41587-020-0548-6. [40] T. Z. DeSantis, P. Hugenholtz, N. Larsen, et al., “Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB,” Appl. Environ. Microbiol., vol. 72, no. 7, pp. 5069–5072, 2006, doi: https://doi.org/10.1128/AEM.03006-05. [41] C. Quast, E. Pruesse, P. Yilmaz, et al., “The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools,” Nucleic Acids Res., vol. 41, no. D1, pp. D590–D596, 2012, doi: https://doi.org/10.1093/nar/gks1219. [42] P. Yilmaz, L. W. Parfrey, P. Yarza, et al., “The SILVA and “all-species living tree project (LTP)"taxonomic frameworks,” Nucleic Acids Res., vol. 42, no. D1, pp. D643–D648, 2014, doi: https://doi.org/10.1093/nar/gkt1209. [43] B. L. Maidak, G. J. Olsen, N. Larsen, R. Overbeek, M. J. McCaughey, and C. R. Woese, “The RDP (ribosomal database project),” Nucleic Acids Res., vol. 25, no. 1, pp. 109–110, 1997, doi: https://doi.org/10.1093/nar/25.1.109. [44] R. Leinonen, H. Sugawara, M. Shumway, and I. N. S. D. Collaboration, “The sequence read archive,” Nucleic Acids Res., vol. 39, no. suppl_1, pp. D19–D21, 2010, doi: https://doi.org/10.1093/nar/gkq1019. [45] M. Kanehisa and S. Goto, “KEGG: Kyoto encyclopedia of genes and genomes,” Nucleic Acids Res., vol. 28, no. 1, pp. 27–30, 2000, doi: https://doi.org/10.1093/nar/28.1.27. [46] S. Kim, P. A. Thiessen, E. E. Bolton, et al., “PubChem substance and compound databases,” Nucleic Acids Res., vol. 44, no. D1, pp. D1202–D1213, 2016, doi: https://doi.org/10.1093/nar/gkv951. [47] D. Wishart, “FooDB: The food database,” FooDB version, vol. 1, 2014. [48] K. Pavelin, J. A. Cham, P. de Matos, C. Brooksbank, G. Cameron, and C. Steinbeck, “Bioinformatics meets user-centred design: a perspective,” PLoS Comput. Biol., vol. 8, no. 7, p. e1002554, 2012, doi: https://doi.org/10.1371/journal.pcbi.1002554. [49] P. De Matos, J. A. Cham, H. Cao, et al., “The enzyme portal: A case study in applying usercentred design methods in bioinformatics,” BMC bioinformatics, vol. 14, pp. 1–15, 2013, doi: https://doi.org/10.1186/1471-2105-14-103. [50] Expasy, [Online]. Available: https://www.expasy.org/. [51] S. Duvaud, C. Gabella, F. Lisacek, H. Stockinger, V. Ioannidis, and C. Durinx, “Expasy, the Swiss Bioinformatics Resource Portal, as designed by its users,” Nucleic Acids Res., vol. 49, no. W1, pp. W216–W227, 2021, doi: https://doi.org/10.1093/nar/gkab225. [52] The online collaborative whiteboard for teams, [Online]. Available: https://www.figma.com/figjam/. [53] The visual collaboration platform for every team: Miro, [Online]. Available: https://miro.com/. [54] The collaborative interface design tool. [Online]. Available: https://www.figma.com/. [55] Adobe xd, [Online]. Available: https://helpx.adobe.com/tw/xd/get-started.html. [56] J. T. Mark Otto, Bootstrap, [Online]. Available: https://getbootstrap.com/. [57] The react component library you always wanted, [Online]. Available: https://mui.com/. [58] Datatables table plug-in for jquery, [Online]. Available: https://datatables.net/. [59] Rawgraphs, [Online]. Available: https://www.rawgraphs.io/. [60] M. Bostock, Data-driven documents, [Online]. Available: https://d3js.org/. [61] Free bootstrap templates, [Online]. Available: https://bootstrapmade.com/. [62] Jquery, [Online]. Available: https://jquery.com/. [63] Zepid, [Online]. Available: https://zepid.readthedocs.io/en/latest/. [64] Django: The web framework for perfectionists with deadlines, [Online]. Available: https://www.djangoproject.com/. [65] Subprocess, [Online]. Available: https://docs.python.org/zh-tw/3/library/subprocess.html. [66] Pulp, [Online]. Available: https://pypi.org/project/PuLP/. [67] 李家岩, Python-pulp 成功大學資訊系作業研究課程教材, [Online]. Available: https://github.com/jasonyoyo/python-pulp. [68] Y.-M. Hung, W.-N. Lyu, M.-L. Tsai, et al., “To compare the performance of prokaryotic taxonomy classifiers using curated 16S full-length rRNA sequences,” Comput. Biol. Med., vol. 145, p. 105416, 2022, doi: https://doi.org/10.1016/j.compbiomed.2022.105416. [69] Twnbiome, [Online]. Available: http://twnbiome.cgm.ntu.edu.tw/. [70] T.-W. Yang, W.-H. Lee, S.-J. Tu, et al., “Enterotype-based analysis of gut microbiota along the conventional adenoma-carcinoma colorectal cancer pathway,” Sci. Rep., vol. 9, no. 1, pp. 1–13, 2019, doi: https://doi.org/10.1038/s41598-019-45588-z. [71] F. Liu, X. Xu, L. Chao, et al., “Alteration of the gut microbiome in chronic kidney disease patients and its association with serum free immunoglobulin light chains,” Front. Immunol., vol. 12, p. 609700, 2021, doi: https://doi.org/10.3389/fimmu.2021.609700. [72] Y. Cao, J. Oh, M. Xue, et al., “Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites,” Science, vol. 378, no. 6618, p. eabm3233, 2022, doi: https://doi.org/10.1126/science.abm3233. [73] K. Sikorska-Zimny and L. Beneduce, “The metabolism of glucosinolates by gut microbiota,” Nutrients, vol. 13, no. 8, p. 2750, 2021, doi: https://doi.org/10.3390/nu13082750. [74] J. M. Macharia, R. W. Mwangi, N. Rozmann, et al., “Medicinal plants with anti-colorectal cancer bioactive compounds: Potential game-changers in colorectal cancer management,” Biomed. & Pharmacother., vol. 153, p. 113383, 2022, doi: https://doi.org/10.1016/j.biopha.2022.113383. [75] L. A. Mendonça, R. dos Santos Ferreira, R. de Cássia Avellaneda Guimarães, et al., “The complex puzzle of interactions among functional food, gut microbiota, and colorectal cancer,” Front. Oncol., vol. 8, p. 325, 2018, doi: https://doi.org/10.3389/fonc.2018.00325. [76] L. Polimeno, M. Barone, A. Mosca, et al., “Soy metabolism by gut microbiota from patients with precancerous intestinal lesions,” Microorganisms, vol. 8, no. 4, p. 469, 2020, doi: https://doi.org/10.3390/microorganisms8040469. [77] I.-S. Kim, W.-S. Yang, and C.-H. Kim, “Beneficial effects of soybean-derived bioactive peptides,” Int. J. Mol. Sci., vol. 22, no. 16, p. 8570, 2021, doi: https://doi.org/10.3390/ijms22168570. [78] C.-Y. Yang and D.-C. Tarng, “Diet, gut microbiome and indoxyl sulphate in chronic kidney disease patients,” Nephrology, vol. 23, pp. 16–20, 2018, doi: https://doi.org/10.1111/nep.13452. [79] P.-Y. Liu, W.-K. Wu, C.-C. Chen, S. Panyod, L.-Y. Sheen, and M.-S. Wu, “Evaluation of compatibility of 16s rRNA V3V4 and V4 amplicon libraries for clinical microbiome profiling,” BioRxiv, pp. 2020–08, 2020, doi: https://doi.org/10.1101/2020.08.18.256818. [80] A. Michielan and R. D'Incà, “Intestinal permeability in inflammatory bowel disease: Pathogenesis, clinical evaluation, and therapy of leaky gut,” Mediat. Inflamm., vol. 2015, 2015, doi: https://doi.org/10.1155/2015/628157. [81] S. Wang, Mixed-integer programming: A guide to computational decision-making, [Online]. Available: https://www.toptal.com/algorithms/mixed-integer-programming. [82] MDChain, 16S rRNA 從次世代到三代定序-生資QIIME2 資料分析趣, [Online]. Available: https://ithelp.ithome.com.tw/users/20151510/ironman/5598. | - |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/88929 | - |
dc.description.abstract | 飲食習慣影響著人類腸道微生物組成。在過去的數十年間,研究已發現腸道微生物可以利用食物消化後的營養素來產生代謝物,與人類生理有著密切關係,也因此腸道菌叢與營養素對人體健康的影響顯得相當重要。然而,至今鮮少有研究著重於利用腸道菌相預測出缺乏的營養素,想要透過文獻尋找基準群體菌相與手邊研究資料進行比較,其過程也相當困難與繁瑣。這份論文提出一款線上分析平台 - NURECON:藉由整合次世代定序微生物 16S 核糖體 RNA 分析流程(QIIME2)、代謝途徑預測工具(PICRUSt2 與 KEGG)以及食物與化合物資料庫(FooDB),預測個人缺乏的營養素並提供飲食建議。該平台從已發表的文獻中,收錄 287 位健康人的腸道菌相,用以建立基準微生物菌相與代謝物組成。NURECON 可以讓使用者上傳自己的 16S 序列資料進行分析,上傳的序列資料將會與平台中的基準群體進行分析及比較,預測缺乏的營養素。最終以視覺化圖表的方式呈現腸道菌相組成、相關的酵素及代謝物分析結果。NURECON 是一款使用者友善便捷的線上平台,其所提供的營養素建議能夠輔助營養師設計食譜或作為研究時的參考依據。本系統網址為:https://nurecon.cgm.ntu.edu.tw/。 | zh_TW |
dc.description.abstract | Dietary habits have been proven to have an impact on the microbial composition and health of the human gut. Over the past decade, researchers have discovered that gut microbiota can use nutrients to produce metabolites that have major implications for human physiology. However, there is no comprehensive system that specifically focuses on identifying nutrient deficiencies based on gut microbiota, making it difficult to interpret and compare gut microbiome data in the literature. This study proposes an analytical platform, NURECON, that can predict nutrient deficiency information in individuals by comparing their metagenomic information to a reference baseline. NURECON integrates a next-generation bacterial 16S rRNA analytical pipeline (QIIME2), metabolic pathway prediction tools (PICRUSt2 and KEGG), and a food compound database (FooDB) to enable the identification of missing nutrients and provide personalized dietary suggestions. Metagenomic information from total number of 287 healthy subjects was used to establish baseline microbial composition and metabolic profiles. Users can upload their 16S sequence data to NURECON for analysis. The uploaded data is analyzed and compared to the baseline for nutrient deficiency assessment. Visualization results include gut microbial composition, related enzymes, and nutrient abundance. NURECON is a user-friendly online platform that provides nutritional advice to support dietitians’ research or menu design. The system is freely available at https://nurecon.cgm.ntu.edu.tw/. | en |
dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2023-08-16T16:24:14Z No. of bitstreams: 0 | en |
dc.description.provenance | Made available in DSpace on 2023-08-16T16:24:14Z (GMT). No. of bitstreams: 0 | en |
dc.description.tableofcontents | 誌謝 v
摘要 vii Abstract ix 目錄 xi 第一章 緒論 1 1.1 研究動機 1 1.2 次世代定序與16S 核糖體RNA 1 1.3 微生物與疾病關係 2 1.4 改善腸道菌相的組成 3 1.5 微生物與代謝物關係 3 1.6 微生物菌相分析 4 1.6.1 分析流程 4 1.6.2 分析工具與網站 5 1.6.3 資料庫資源 5 1.7 使用者中心設計導入生物資訊網站 7 1.8 具體目標 10 第二章 材料與方法 11 2.1 NURECON 系統概述 11 2.2 前端開發與資料視覺化 12 2.2.1 Bootstrap 網頁前端函式庫 13 2.2.2 AJAX 非同步請求技術 15 2.2.3 jQuery 與Datatable 函式庫 15 2.2.4 RAWGraphs 與zEpid 資料視覺化函式庫 16 2.3 後端開發 19 2.3.1 系統開發套件 19 2.3.2 生物資訊學軟體與資料庫 20 2.3.3 菌相及營養評估的架構設計與資料比較 26 2.3.4 系統流程 32 2.4 驗證資料集 34 第三章 結果 35 3.1 系統開發成果 35 3.1.1 說明文件與範例分析資料 35 3.1.2 管理與選擇欲分析的專案 35 3.1.3 微生物菌相組成 38 3.1.4 酵素與營養化合物 38 3.1.5 食物評估推薦結果 41 3.1.6 整合與延伸相關菌相分析工具 46 3.2 驗證資料與分析結果 48 3.2.1 大腸癌患者 48 3.2.2 慢性腎臟病患者 51 第四章 討論 55 4.1 驗證資料討論 55 4.1.1 大腸癌患者 55 4.1.2 慢性腎臟病患者 56 4.2 系統限制 57 4.2.1 菌相、營養素及食物關係 57 4.2.2 忌口食物考量 57 4.2.3 基準腸道菌相群體資料庫組成與驗證 57 第五章 總結 59 第六章 未來的研究方向 61 參考文獻 63 附錄A 引用文獻之圖片 71 附錄B 補充資料表格 75 B.1 大腸癌患者實驗組與健康對照組的菌相分析 75 B.2 慢性腎臟病患者實驗組與健康對照組的菌相分 90 附錄C 程式碼 105 C.1 Bootstrap RWD Breakpoint 105 C.2 Subprocess.run() 105 C.3 PuLP module 106 C.4 QIIME2 dada2 denoise-paired 107 | - |
dc.language.iso | zh_TW | - |
dc.title | NURECON:利用宏基因體資料建立新型營養攝取需求線上系統 | zh_TW |
dc.title | NURECON:To Establish a Novel Online System for Determining Nutrition Requirement Based on Metagenomic Sequencing Data | en |
dc.type | Thesis | - |
dc.date.schoolyear | 111-2 | - |
dc.description.degree | 碩士 | - |
dc.contributor.coadvisor | 莊曜宇 | zh_TW |
dc.contributor.coadvisor | Eric Y. Chuang | en |
dc.contributor.oralexamcommittee | 陳立涵;潘敏雄;賴亮全 | zh_TW |
dc.contributor.oralexamcommittee | Li-Han Chen;Min-Hsiung Pan;Liang-Chuan Lai | en |
dc.subject.keyword | 宏基因體,16S核糖體RNA,線上系統,使用者友善設計,精準營養,資料庫, | zh_TW |
dc.subject.keyword | Metagenomics,16S rRNA,Web-based system,User-friendly Design,Precision nutrition,Database, | en |
dc.relation.page | 107 | - |
dc.identifier.doi | 10.6342/NTU202301242 | - |
dc.rights.note | 同意授權(全球公開) | - |
dc.date.accepted | 2023-08-09 | - |
dc.contributor.author-college | 生物資源暨農學院 | - |
dc.contributor.author-dept | 生物科技研究所 | - |
顯示於系所單位: | 生物科技研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-111-2.pdf | 12.82 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。